Quartuccio, N.; Ialuna, S.; Pulizzi, S.; D’Oppido, D.; Antoni, M.; Moreci, A.M. The Correlation of Body Mass Index with Risk of Recurrence in Post-Menopausal Women with Breast Cancer Undergoing fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. J. Clin. Med.2024, 13, 1575.
Quartuccio, N.; Ialuna, S.; Pulizzi, S.; D’Oppido, D.; Antoni, M.; Moreci, A.M. The Correlation of Body Mass Index with Risk of Recurrence in Post-Menopausal Women with Breast Cancer Undergoing fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. J. Clin. Med. 2024, 13, 1575.
Quartuccio, N.; Ialuna, S.; Pulizzi, S.; D’Oppido, D.; Antoni, M.; Moreci, A.M. The Correlation of Body Mass Index with Risk of Recurrence in Post-Menopausal Women with Breast Cancer Undergoing fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. J. Clin. Med.2024, 13, 1575.
Quartuccio, N.; Ialuna, S.; Pulizzi, S.; D’Oppido, D.; Antoni, M.; Moreci, A.M. The Correlation of Body Mass Index with Risk of Recurrence in Post-Menopausal Women with Breast Cancer Undergoing fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. J. Clin. Med. 2024, 13, 1575.
Abstract
To investigate whether high body mass index (BMI) increases the risk of recurrence and corre-lates with higher glucose uptake in recurrent lesions in post-menopausal female patients with breast cancer. The hospital database was searched to retrieve breast cancer patients, who had undergone an [18F]FDG PET/CT scan before neoadjuvant chemotherapy and curative-intent sur-gery. BMI was calculated at the baseline [18F]FDG PET/CT scan. There was a median follow-up of 5 years after the baseline PET/CT scan to identify: recurrence in the breast (T_rec); lymph nodes (N_rec); distant locations (M_rec). Furthermore, SUVmax was measured in the sites of recur-rence. A chi-square test was used to investigate any difference in the frequency of any recur-rence, T_rec, N_rec, and M_rec between overweight women (BMI≥25 kg/m2) and women with a BMI<25 kg/m2 (p<0.05). SUVmax, was compared using a t-test (p<0.05) between the two groups. A total of post-menopausal 142 women (BMI: 26.84±5.59; 84 overweight and 58 with normal weight) were retrieved. There were 48 recurrences at the follow-up. The chi-square test demon-strated in overweight women an increased frequency of any recurrence (35 vs. 13; p=0.025) and T_rec (15 vs. 2; p=0.018) and a higher T_rec SUVmax (4.74±2.90 vs. 1.85 ± 0.63; p=0.09) compared to women with a BMI<25 kg/m2. BMI seems to correlate with an increased rate of recurrence, espe-cially in the breast, and a higher glucose uptake in post-menopausal patients with recurrent breast cancer.
Keywords
PET/CT; breast cancer; body mass index
Subject
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
,
,
